LON:BTEC Holdings Information

LON:BTEC is an equity ETF with a total of 271 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 7.77%, Amgen at 7.73%, Gilead Sciences at 7.59%, Regeneron Pharmaceuticals at 6.22%, and AstraZeneca at 4.43%.

Total Holdings

271

Top 10 Percentage

45.65%

Asset Class

Equity

ETF Category

Health Care

Assets

521.44M

PE Ratio

25.32

Top 25 Holdings

As of Jul 3, 2025

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	7.77%	92,843
2	AMGN	Amgen Inc.	7.73%	142,353
3	GILD	Gilead Sciences, Inc.	7.59%	372,762
4	REGN	Regeneron Pharmaceuticals, Inc.	6.22%	62,393
5	AZN	AstraZeneca PLC	4.43%	350,286
6	ALNY	Alnylam Pharmaceuticals, Inc.	4.07%	67,350
7	BIIB	Biogen Inc.	2.10%	86,926
8	SMMT	Summit Therapeutics Inc.	1.97%	440,457
9	INSM	Insmed Incorporated	1.92%	107,995
10	ARGX	argenx SE	1.85%	18,710
11	ILMN	Illumina, Inc.	1.72%	93,901
12	RPRX	Royalty Pharma plc	1.65%	249,412
13	SNY	Sanofi	1.47%	166,863
14	UTHR	United Therapeutics Corporation	1.43%	26,744
15	INCY	Incyte Corporation	1.43%	114,801
16	NBIX	Neurocrine Biosciences, Inc.	1.38%	58,681
17	EXEL	Exelixis, Inc.	1.36%	161,884
18	MRNA	Moderna, Inc.	1.27%	229,402
19	BMRN	BioMarin Pharmaceutical Inc.	1.19%	113,740
20	BNTX	BioNTech SE	1.19%	59,259
21	VTRS	Viatris Inc.	1.18%	696,192
22	ASND	Ascendis Pharma A/S	1.14%	35,997
23	TEM	Tempus AI, Inc.	1.11%	99,656
24	ONC	BeOne Medicines Ltd.	1.10%	24,652
25	MEDP	Medpace Holdings, Inc.	1.00%	17,037

As of Jul 3, 2025

Showing 25 of 271

Subscribe to see the full list